Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Head and Neck Neoplasms 5Stomatitis 3Neoplasms 3Mucositis 3Xerostomia 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pain 1Oral Ulcer 1Laryngeal Diseases 1Carcinoma, Squamous Cell 1

Interventions

Radiotherapy 8Radiation 4Cisplatin 3Amifostine 3Acupuncture Therapy 3Surveys and Questionnaires 2Surgical Procedures, Operative 2Standard of Care 2Saliva, Artificial 2Pilocarpine 2Oral Hygiene 2Low-Level Light Therapy 2Iodine-131 2Chewing Gum 2pegfilgrastim 1citric acid, deuterium oxide solution 1Xylitol 1Transcutaneous Electric Nerve Stimulation 1Smell 1Selenomethionine 1Paclitaxel 1Mouthwashes 1Lansoprazole 1Hypnosis 1Health Education, Dental 1Granulocyte Colony-Stimulating Factor 1Genetic Engineering 1Fluorouracil 1Filgrastim 1Fibroblast Growth Factor 7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Xerostomia × Fibroblast Growth Factor 7 × Head & Neck × Clear all
NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Swedish Orphan Biovitrum

Phase 3 Completed
188 enrolled 19 charts
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡